Skip to content

The Effects of Sacroiliac Joint Manual Therapy on Autonomic Nervous System and Lower Abdominal Pain in Women in Their 20s With Primary Dysmenorrhea

The Effects of Sacroiliac Joint Manual Therapy on Autonomic Nervous System and Lower Abdominal Pain in Women in Their 20s With Primary Dysmenorrhea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05752864
Enrollment
40
Registered
2023-03-03
Start date
2023-04-30
Completion date
2023-08-30
Last updated
2023-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dysmenorrhea

Brief summary

Disorders of the autonomic nervous system are considered another possible cause of dysmenorrhea. spinal manual threapty is acting on the parasympathetic and sympathetic nerves. The sacrum affects all vertebrae, which affects the position of this bone, is thought to have a lot to do with dysmenorrhea. In this study, by applying spinal manual threapty threapty to the sacroiliac joint in women in their 20s with primary dysmenorrhea, we tried to present an effective treatment method by evaluating the function of the autonomic nervous system and confirming the occurrence of pain in the lower abdomen.

Interventions

BEHAVIORALspine manual therapy

The manual treatment method applied to the sacroiliac joint used high-velocity, low amplitude (HVLA).

In the physical therapy used in this study, it was applied for 20 minutes using conventionally used superficial heat therapy.

Sponsors

Sahmyook University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* Women between the ages of 20-29 * Regular menstrual cycle (24-32 days) * Those who have had symptoms of primary dysmenorrhea for at least 1 year * Those who have lower back pain symptoms related to menstrual pain of 5 or higher on the Visual Analysis Scale (VAS) * The body mass index is between 20-30 * Positive reaction to Gillet test

Exclusion criteria

* pelvic inflammatory disease * uterine fibroids, polycystic ovary syndrome. Those with gynecological findings such as endometriosis * Those who have used an intrauterine contraceptive device * Those who took birth control pills or nonsteroidal anti-inflammatory drugs at the time of the experiment

Design outcomes

Primary

MeasureTime frameDescription
Heart Rate VariabilityChange from baseline after intervention at 4 weeks, follow-up at 4 weeksAutonomic nervous system balance tester (SA3000new, Medicore Co. Korea) was used. The subjects placed electrodes on three areas (left arm, left leg, right leg) while lying down and performed for 3 minutes.

Secondary

MeasureTime frameDescription
Visual analog scaleChange from baseline after intervention at 4 weeks, follow-up at 4 weeksOn a line consisting of 10 cm, 0 at either end represents 'no pain' and 10 represents 'worst pain'.
Pressure pain thresholdChange from baseline after intervention at 4 weeks, follow-up at 4 weeksThe test determines the amount of pressure over a given area in which a steadily increasing nonpainful pressure stimulus turns into a painful pressure sensation. With the participant seated comfortably, the examiner identified the sacroiliac joint and applied pressure with the algometer perpendicular to the skin surface until the participant made an Ah sound. * Lower pressure pain thresholds indicate higher sensitivity to pressure and a lower pain tolerance. * Higher pressure pain thresholds suggest lower sensitivity and a higher pain tolerance.
Menstrual distress questionnaireChange from baseline after intervention at 4 weeks, follow-up at 4 weeksThe Menstrual Distress Questionnaire (MDQ) is a standard method for measuring cyclical menstrual cycle symptoms. The MDQ can differentiate between cyclical and non-cyclical changes in somatic symptoms, mood and behavior, and arousal. -The measured scores range from 0 to 185; higher scores indicate severe dysmenorrhea symptoms.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026